CareTrust REIT (CTRE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
19 Dec, 2025Executive summary
Achieved record quarterly and full-year results in 2024, with net income of $125.1M and normalized FFO and FAD growth.
Completed $1.52B in new investments, expanding the portfolio to 406 properties and 42,670 beds/units across 34 states.
Maintains a disciplined approach to underwriting and portfolio management, focusing on long-term FFO per share growth.
Raised over $1.5B in equity and upsized revolving credit line to $1.2B, with no outstanding borrowings and $205M cash on hand.
Positioned for double-digit FFO per share growth in 2025, even without additional investments.
Financial highlights
Q4 2024 revenues rose to $86.9M from $59.7M year-over-year; full-year revenues reached $296.3M, up from $217.8M.
Net income for Q4 2024 was $52.1M; full-year net income was $125.1M.
Normalized FFO for Q4 2024 was $72.9M ($0.40/share); normalized FAD was $74.3M ($0.41/share).
Dividends declared per share were $0.29 in Q4 2024, with a payout ratio of 71%–83%.
Ended the quarter with $180M in cash after funding investments and dividends.
Outlook and guidance
2025 guidance: net income per share of $1.35–$1.39, normalized FFO per share of $1.68–$1.72, and normalized FAD per share of $1.72–$1.76.
Projected total cash rental revenues of $279M and interest income from financing receivables of $11.5M.
Guidance assumes no additional investments or debt/equity issuances in 2025 and 2.5% CPI rent escalations.
Expected FFO per share growth of 12%–14.6% and FAD per share growth of 11.8%–14.4%.
Dividend maintained at $0.29/share quarterly; annualized payout ratio of 73% on normalized FFO.
Latest events from CareTrust REIT
- Record capital deployment and performance-driven executive pay defined 2025.CTRE
Proxy filing24 Mar 2026 - Proxy seeks approval for director elections, executive pay, and auditor ratification after a record growth year.CTRE
Proxy Filing13 Mar 2026 - Definitive proxy statement outlines annual meeting proposals and confirms board oversight.CTRE
Proxy Filing13 Mar 2026 - Record 2025 growth and robust 2026 outlook with strong FFO, FAD, and pipeline momentum.CTRE
Q4 20254 Mar 2026 - Double-digit FFO growth, robust investments, and industry-leading returns drive shareholder value.CTRE
Investor presentation2 Mar 2026 - Q2 2024 saw record investments, robust growth, and historic low leverage with strong liquidity.CTRE
Q2 20242 Feb 2026 - Q3 2024 net income hit $33.4M, with record investments and a robust pipeline.CTRE
Q3 202417 Jan 2026 - $817M acquisition of 137 U.K. care homes brings accretion, diversification, and growth.CTRE
M&A Announcement25 Dec 2025 - Q1 2025 saw record earnings, a dividend hike, and a major UK acquisition set to close.CTRE
Q1 202523 Dec 2025